Gireesh Kumar Eri

About

Gireesh Kumar Eri is an academician and researcher in the field of Pharmaceutical Sciences with expertise in Pharmaceutical Analysis, Analytical Method Development, Quality by Design (QbD), Green Analytical Chemistry, and Drug Discovery Research. His research focuses on the development and validation of analytical methods, greenness assessment of pharmaceutical analytical procedures, natural product research, in silico drug discovery, and the characterization of bioactive compounds from medicinal plants.

He has actively contributed to teaching, research, and academic administration, guiding undergraduate and postgraduate students in pharmaceutical sciences. His scholarly interests include chromatographic method development, HPLC and LC–MS applications, regulatory compliance in pharmaceutical analysis, environmental sustainability in analytical chemistry, and artificial intelligence applications in drug discovery and development.

Gireesh Kumar has authored and co-authored research articles, conference presentations, book chapters, and intellectual property filings. His current research endeavors involve Analytical Quality by Design (AQbD)-based method development, environmental fate prediction of pharmaceutical compounds, and the identification of novel therapeutic candidates through computational and experimental approaches. He is committed to advancing pharmaceutical education, fostering research excellence, and promoting sustainable scientific practices.

Employment

• Annamacharya College of Pharmacy Associate Professor
  2012 - Present
• Narayana Pharmacy College Assistant Professor
  2010 - 2012

Education

• Jawaharlal Nehru Technological University Anantapur Ph.D.
  2014 - Present
• Jawaharlal Nehru Technological University Hyderabad Institute of Science & Technology M.Pharmacy
  2008 - 2010
• Sree Vidyanikethan College of Pharmacy B.Pharmacy
  2004 - 2008

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• From Methods to Knowledge Space: An AQbD - Driven Critical Review of Trelagliptin HPLC Methods (2015 – 2025)
  Future Journal of Pharmaceuticals and Health Sciences 2026 DOI: 10.26452/fjphs.v6i1.566
  +Save
• Review on reversed - phase chromatographic analysis of bexagliflozin: multifactorial effects on separation performance, and an Ich Q14 - aligned AQbD framework
  Future Journal of Pharmaceuticals and Health Sciences 2026 DOI: 10.26452/fjphs.v6i2.565
  +Save
• Structural Characterization and In-silico Evaluation of Bioactive compounds from Neisosperma Oppositifolium Leaves as Anti-diabetic and Anti-cancer agents
  Oriental Journal Of Chemistry 2025 DOI: 10.13005/ojc/410602
  +Save
• FOLATE-CONJUGATED LIPOSOMAL NANOCARRIERS FOR TARGETED SIRNA DELIVERY IN OVARIAN CANCER THERAPY
  The Patent Office, India 2025
  +Save
• Analytical Procedure Development by Quality by Design
  BSP Books Pvt. Ltd. (1 January 2024); 040-23445688 2024
  +Save
• Utilizing central composite design (CCD) in the optimization of new HPLC-PDA method for the assay of daridorexant: Application to the analysis in bulk and tablet dosage forms
  Analytical Chemistry Letters 2024 DOI: 10.1080/22297928.2024.2353056
  +Save
• A comprehensive review on QbD driven analytical procedures developed for the analysis of various drugs
  Journal of Liquid Chromatography and Related Technologies 2023 DOI: 10.1080/10826076.2023.2204238
  +Save
• A THERMO-GELLING SOLUTION AS UNIQUE MATERIALS FOR THERAPEUTIC AND BIOSENSOR APPLICATIONS
  The Patent Office, India 2022
  +Save
• EVALUATION OF A RECONSTITUTABLE DRY SUSPENSION TO IMPROVE THE DISSOLUTION OF POORLY WATER-SOLUBLE CELECOXIB
  The Patent Office, India 2022
  +Save
• Detection of various adulterants present in marketed milk samples
  World Journal of Pharmacy and Pharmaceutical Sciences 2021
  +Save